Clinical trial
A Phase-1 Study Comparing the Pharmacokinetics of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal Function
NCT02775955 is registered in ClinicalTrials.gov with Pharmaceutical Project Solutions, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase-1 Study Comparing the Pharmacokinetics of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal Function
- Lead sponsor
- Pharmaceutical Project Solutions, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- October 31, 2016
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy